Skip to content

Role of Uterine Artery Embolization in Adenomyosis

Role of Uterine Artery Angioembolization in Management of Uterine Adenomyosis.

Status
UNKNOWN
Phases
Early Phase 1
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05597644
Enrollment
30
Registered
2022-10-28
Start date
2023-01-01
Completion date
2025-12-31
Last updated
2022-10-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Adenomyosis

Brief summary

Management of symptomatizing women diagnosed with uterine adenomyosis, by uterine artery angioembolization as a minimally invasive replacement for hysterectomy. This is followed by assessment of the symptoms and MRI of the pelvis after 3 months.

Detailed description

Adenomyosis is defined by the abnormal location of endometrial tissue within the myometrium associated with hypertrophy or hyperplasia of the myometrial stroma. Although pathogenesis and etiology of adenomyosis remain unknown, two main theories have been proposed: invagination of the endometrial basal layer and metaplasia of embryonic stem cells. Despite the absence of specific (pathognomonic) diagnostic features for uterine adenomyosis, typical symptoms include menorrhagia, chronic pelvic pain, and dysmenorrhea. For more than a century, diagnosis was dependent on histopathologic examination of post-hysterectomy specimens till the introduction of noninvasive ultrasound and MR techniques. Since then, several studies have illustrated high sensitivities and specificities for both two-dimensional transvaginal sonography (TVS) and magnetic resonance imaging (MRI). Current treatment options for symptomatic adenomyosis include hysterectomy, medication, conservative surgery, or minimally invasive techniques including uterine artery embolization. To date, hysterectomy remains the definitive treatment. This is mainly due to difficult diagnosis, the diffuse nature of the disease, and little evidence-based literature needed to standardize treatments. This consequently results in a management dilemma, particularly in symptomatic patients who wish to preserve their uterus. Uterine artery embolization is the use of transarterial catheters aiming to induce more than 34% necrosis within adenomyotic tissues. Vascular access is gained through a femoral or radial artery puncture using 4-6-French (F) arterial sheath for femoral and 4-F sheath for radial access. Under fluoroscopic guidance, aortography is followed by selective and super selective arteriography using 4-5-F catheters for the internal iliac and 2-3-F microcatheters for the uterine artery and its branches respectively. Embolization is usually performed using variable-sized permanent particulate agents.

Interventions

PROCEDURETrans-arterial uterine artery embolization

transarterial angioembolization of uterine artery

Sponsors

Assiut University
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

Angioembolization of uterine artery by PVA particles

Eligibility

Sex/Gender
FEMALE
Age
30 Years to 50 Years
Healthy volunteers
No

Inclusion criteria

* Symptomatizing women (pelvic pain and/or bleeding) between ages 30-50 who are not keen on hysterectomy.

Exclusion criteria

* Women who desire further child bearing (not completed their family yet). * Impaired coagulation profile. * Hypersensitivity to intravenous contrast media. * Decompensated congestive heart failure. * Hypertensive crisis. * Stroke or CVA. * Renal failure.

Design outcomes

Primary

MeasureTime frameDescription
uterine artery embolization in management of adenomyosisbaselinestudy the effect of embolization on symptoms and imaging findings

Contacts

Primary ContactMoustafa Al-Hussaini, Specialist
moustafa71989@gmail.com01023646463
Backup ContactMahmoud Refaat, Lecturer
mahmoud.abdelzaher@med.au.edu.eg01003133736

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026